HUP0301130A3 - Electrospun pharmaceutical compositions - Google Patents

Electrospun pharmaceutical compositions

Info

Publication number
HUP0301130A3
HUP0301130A3 HU0301130A HUP0301130A HUP0301130A3 HU P0301130 A3 HUP0301130 A3 HU P0301130A3 HU 0301130 A HU0301130 A HU 0301130A HU P0301130 A HUP0301130 A HU P0301130A HU P0301130 A3 HUP0301130 A3 HU P0301130A3
Authority
HU
Hungary
Prior art keywords
pharmaceutical compositions
electrospun
electrospun pharmaceutical
compositions
pharmaceutical
Prior art date
Application number
HU0301130A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of HUP0301130A2 publication Critical patent/HUP0301130A2/hu
Publication of HUP0301130A3 publication Critical patent/HUP0301130A3/hu

Links

Classifications

    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
    • D01D5/00—Formation of filaments, threads, or the like
    • D01D5/0007—Electro-spinning
    • D01D5/0015—Electro-spinning characterised by the initial state of the material
    • D01D5/003—Electro-spinning characterised by the initial state of the material the material being a polymer solution or dispersion
    • D01D5/0038—Electro-spinning characterised by the initial state of the material the material being a polymer solution or dispersion the fibre formed by solvent evaporation, i.e. dry electro-spinning
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
    • D01D5/00—Formation of filaments, threads, or the like
    • D01D5/0007—Electro-spinning
    • D01D5/0015—Electro-spinning characterised by the initial state of the material
    • D01D5/0023—Electro-spinning characterised by the initial state of the material the material being a polymer melt
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F1/00—General methods for the manufacture of artificial filaments or the like
    • D01F1/02—Addition of substances to the spinning solution or to the melt
    • D01F1/10—Other agents for modifying properties

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Communicable Diseases (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Obesity (AREA)
  • Textile Engineering (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Mechanical Engineering (AREA)
  • Toxicology (AREA)
  • Dispersion Chemistry (AREA)
  • Virology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Manufacturing & Machinery (AREA)
  • Psychiatry (AREA)
HU0301130A 2000-01-28 2001-01-25 Electrospun pharmaceutical compositions HUP0301130A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17868200P 2000-01-28 2000-01-28
PCT/US2001/002399 WO2001054667A1 (en) 2000-01-28 2001-01-25 Electrospun pharmaceutical compositions

Publications (2)

Publication Number Publication Date
HUP0301130A2 HUP0301130A2 (hu) 2003-09-29
HUP0301130A3 true HUP0301130A3 (en) 2006-07-28

Family

ID=22653497

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0301130A HUP0301130A3 (en) 2000-01-28 2001-01-25 Electrospun pharmaceutical compositions

Country Status (18)

Country Link
EP (1) EP1251829A4 (de)
JP (1) JP2003521493A (de)
KR (1) KR100806412B1 (de)
CN (1) CN1223340C (de)
AR (1) AR028204A1 (de)
AU (1) AU772830B2 (de)
BR (1) BR0107869A (de)
CA (1) CA2396640A1 (de)
HU (1) HUP0301130A3 (de)
IL (1) IL150642A0 (de)
MX (1) MXPA02007298A (de)
MY (1) MY129356A (de)
NO (1) NO20023338L (de)
NZ (1) NZ519992A (de)
PL (1) PL356924A1 (de)
TW (1) TWI289061B (de)
WO (1) WO2001054667A1 (de)
ZA (1) ZA200205989B (de)

Families Citing this family (116)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9910505D0 (en) 1999-05-06 1999-07-07 Electrosols Ltd A method and apparatus for manufacturing consumable tablets
AU2438702A (en) * 2000-10-18 2002-04-29 Univ Virginia Commonwealth Electroprocessing in drug delivery and cell encapsulation
JP2010163435A (ja) * 2000-11-17 2010-07-29 Virginia Commonwealth Univ Intellectual Property Foundation 電気処理されたコラーゲン
DE60135019D1 (de) * 2000-11-17 2008-09-04 Univ Virginia Commonwealth Elektroverarbeitetes kollagen
JP2004531652A (ja) * 2001-03-20 2004-10-14 ナイキャスト リミテッド 耐キンク形成性が改良された重合体繊維管形構造体
US6685956B2 (en) * 2001-05-16 2004-02-03 The Research Foundation At State University Of New York Biodegradable and/or bioabsorbable fibrous articles and methods for using the articles for medical applications
GB0123951D0 (en) * 2001-10-05 2001-11-28 Glaxo Group Ltd Therapies for treating respiratory diseases
JP2005523262A (ja) 2002-02-01 2005-08-04 ファイザー・プロダクツ・インク 薬物及び親油性ミクロ相形成物質の非晶質分散物の医薬組成物
KR100549140B1 (ko) 2002-03-26 2006-02-03 이 아이 듀폰 디 네모아 앤드 캄파니 일렉트로-브로운 방사법에 의한 초극세 나노섬유 웹제조방법
JP4969768B2 (ja) 2002-04-04 2012-07-04 ザ ユニバーシティ オブ アクロン 不織繊維集成体
US8367570B2 (en) 2002-04-04 2013-02-05 The University Of Akron Mechanically strong absorbent non-woven fibrous mats
WO2003087443A1 (en) * 2002-04-11 2003-10-23 Secant Medical, Inc. Covering process using electrospinning of very small fibers
US20060083784A1 (en) * 2002-08-07 2006-04-20 Smithkline Beecham Corporation Amorphous pharmaceutical compositions
TW200410714A (en) * 2002-08-07 2004-07-01 Smithkline Beecham Corp Electrospun amorphous pharmaceutical compositions
WO2004062697A2 (en) 2003-01-07 2004-07-29 Tufts University Silk fibroin materials and use thereof
BRPI0413277A (pt) 2003-08-04 2006-10-10 Pfizer Prod Inc composições farmacêuticas de adsorvatos de medicamentos amorfos e materiais que formam microfases lipofìlicas
WO2005065657A2 (en) 2003-12-31 2005-07-21 Pfizer Products Inc. Solid compositions of low-solubility drugs and poloxamers
JP4526851B2 (ja) * 2004-03-31 2010-08-18 明彦 谷岡 多糖類のナノスケールの繊維および成形体
WO2006006746A1 (en) * 2004-07-09 2006-01-19 Hak-Yong Kim Polymer particles, and a method for manufacturing the same
CN100577720C (zh) * 2005-03-21 2010-01-06 中国科学院化学研究所 可生物降解及吸收的聚合物纳米纤维膜材料及制法和用途
JP2006299459A (ja) * 2005-04-20 2006-11-02 National Institute For Materials Science 生分解性高分子不織布チューブの製造方法
CN1300393C (zh) * 2005-07-01 2007-02-14 中国科学院长春应用化学研究所 超细纤维药物剂型的乳液电纺丝制备方法
US20090107495A1 (en) * 2005-07-21 2009-04-30 National Institute For Materials Science Device for inhalation of medicine
JP4787585B2 (ja) * 2005-09-29 2011-10-05 帝人株式会社 静電紡糸法による繊維構造体の製造方法
CN100556399C (zh) * 2005-12-23 2009-11-04 中国科学院广州化学研究所 一种肠靶向型药物控释纤维及其制备方法
US8367112B2 (en) 2006-02-28 2013-02-05 Alkermes Pharma Ireland Limited Nanoparticulate carverdilol formulations
KR100824719B1 (ko) * 2006-09-04 2008-04-24 주식회사 아모메디 전분함유 나노섬유 부직포로 이루어진 생분해성 식품포장재 및 그 제조방법
WO2009120365A2 (en) 2008-03-27 2009-10-01 Agigma, Inc. Methods and compositions for the delivery of agents
US8273333B2 (en) 2008-04-16 2012-09-25 The Procter & Gamble Company Non-lathering personal care composition in the form of an article
WO2010015419A2 (de) 2008-08-08 2010-02-11 Basf Se Wirkstoffhaltige fasernflächengebilde auf basis von biopolymeren, ihre anwendungen und verfahren zu ihrer herstellung
JP2011530661A (ja) 2008-08-08 2011-12-22 ビーエーエスエフ ソシエタス・ヨーロピア 活性成分の制御放出を伴う有効成分含有繊維表面構造体、その使用、およびその生産のための方法
CN101721751B (zh) * 2008-10-10 2013-01-02 张阳德 负载了缓释细胞生长因子的具有内核的中空二氧化硅球的人体组织工程支架及其制法和用途
US20100291182A1 (en) * 2009-01-21 2010-11-18 Arsenal Medical, Inc. Drug-Loaded Fibers
KR101065255B1 (ko) * 2009-02-13 2011-09-16 김근형 생분해성 폴리머의 전기방사를 이용한 신규 약물 전달 시스템
CN101559242B (zh) * 2009-05-22 2015-07-29 广州迈普再生医学科技有限公司 一种可同时作为药物缓释体系的纳米人工硬脑膜及其制备方法
WO2011029777A1 (de) 2009-09-11 2011-03-17 Basf Se Verfahren zur herstellung von beschichteten polymerfasern
US9295859B2 (en) 2009-12-08 2016-03-29 The Procter & Gamble Company Porous, dissolvable solid substrate and surface resident coating comprising matrix microspheres
WO2011103152A1 (en) 2010-02-16 2011-08-25 The Procter & Gamble Company A porous, dissolvable solid substrate and surface resident coating comprising a zync pyrithione
CN101816627B (zh) * 2010-04-16 2012-03-07 浙江大学 一种协同治疗型多物质缓释滴眼剂及制备方法
BR112013000078A2 (pt) 2010-07-02 2020-12-01 The Procter & Gamble Company métodos para aplicação de um ativo de cuidados com a saúde mediante a administração de artigos pessoais de cuidados com a saúde que compreendem um filamento
US20180163325A1 (en) 2016-12-09 2018-06-14 Robert Wayne Glenn, Jr. Dissolvable fibrous web structure article comprising active agents
BR112013000044B1 (pt) 2010-07-02 2022-01-04 The Procter & Gamble Company Método para a distribuição de agentes ativos a artigos de tecido ou superfícies duras
WO2012003319A2 (en) 2010-07-02 2012-01-05 The Procter & Gamble Company Filaments comprising an active agent nonwoven webs and methods for making same
EP2588652B1 (de) * 2010-07-02 2019-06-12 The Procter and Gamble Company Verfahren zur behandlung eines textilerzeugnisses
AU2011272839B2 (en) 2010-07-02 2015-04-02 The Procter & Gamble Company Methods of delivering a health care active by administering personal health care articles comprising a filament
PL2588288T3 (pl) 2010-07-02 2016-04-29 Procter & Gamble Proces wytwarzania powłok z siatek włókninowych
RU2553295C2 (ru) 2010-07-02 2015-06-10 Дзе Проктер Энд Гэмбл Компани Моющий продукт и способы его изготовления
RU2012154298A (ru) * 2010-07-02 2014-08-10 Дзе Проктер Энд Гэмбл Компани Филаменты, содержащие пригодные для приема внутрь активные агенты, нетканые полотна и способы их изготовления
CN101915797B (zh) * 2010-07-27 2011-09-28 北京师范大学 一种静电纺丝固定化漆酶电极的制备方法
WO2012070028A1 (en) * 2010-11-26 2012-05-31 University Of The Witwatersrand, Johannesburg A pharmaceutical dosage form
WO2012084427A1 (en) 2010-12-22 2012-06-28 Unilever Nv Compositions comprising structured non-aqueous liquid phase
WO2012084441A1 (en) 2010-12-22 2012-06-28 Unilever Nv Compositions in the form of fibres
CZ303244B6 (cs) 2011-01-17 2012-06-13 Elmarco S.R.O. Nosic pro oromukosální, zejména pro sublingvální aplikaci fyziologicky aktivních látek
CN102251317B (zh) * 2011-05-18 2013-01-16 东华大学 一种药物释放可控的电纺纤维的制备方法
WO2013124869A2 (en) * 2012-02-21 2013-08-29 Amrita Vishwa Vidyapeetham University The art, method,manner process and system of fibrous bio-degradable polymeric wafers for the local delivery of therapeutic agents in combinations
CN102631715A (zh) * 2012-05-04 2012-08-15 江南大学 一种抗凝血纳米纤维膜的制备方法
CN102670483B (zh) * 2012-05-09 2014-04-02 上海交通大学 一种用于高血脂症治疗的静电纺丝纤维膜制剂及其制备方法
CN102697727B (zh) * 2012-06-12 2014-01-08 东华大学 一种利用静电纺丝技术制备自组装酮洛芬脂质体的方法
KR101454360B1 (ko) 2012-08-31 2014-10-24 서울대학교산학협력단 파에도닥틸룸 트리코르누툼 추출물을 함유하는 젤라틴 나노섬유 지지체 및 이를 이용한 창상피복재
WO2014059252A2 (en) 2012-10-12 2014-04-17 The Procter & Gamble Company Personal care composition in the form of a dissolvable article
CZ308409B6 (cs) * 2013-02-26 2020-08-05 Elmarco S.R.O. Přípravek pro aplikaci alespoň jedné biologicky a/nebo farmaceuticky aktivní látky
CN105246469A (zh) 2013-03-12 2016-01-13 活性纤维有限公司 纳米纤维和生物活性组合物及相关方法
EP2813212A1 (de) 2013-06-10 2014-12-17 Zentiva, a.s. Arzneimittel-Formulierung, einsetzend API in Nanofasern
US10202636B2 (en) * 2013-12-24 2019-02-12 General Electric Company Electrospun fibers for protein stabilization and storage
JP6362226B2 (ja) 2014-04-22 2018-07-25 ザ プロクター アンド ギャンブル カンパニー 溶解性固体構造物の形態の組成物
US9937111B2 (en) 2014-05-05 2018-04-10 The Procter & Gamble Company Consumer product comprising a fibrous web solid structure with a silicone conditioning agent coating
US9861558B2 (en) 2014-05-05 2018-01-09 The Procter & Gamble Company Methods of forming an aqueous treatment liquor by dissolving a porous solid with a benefit agent coating
US9867762B2 (en) 2014-05-05 2018-01-16 The Procter & Gamble Company Consumer product comprising a porous dissolvable solid structure and silicone conditioning agent coating
US9827173B2 (en) 2014-05-05 2017-11-28 The Procter & Gamble Company Porous dissolvable solid structure with two benefit agents and methods of forming an aqueous treatment liquor therefrom
US9877899B2 (en) 2014-05-05 2018-01-30 The Procter & Gamble Company Consumer product comprising a fibrous web structure with a silicone conditioning agent coating
US9861559B2 (en) 2014-05-05 2018-01-09 The Procter & Gamble Company Consumer product comprising a porous, dissolvable, fibrous web solid structure with a silicone coating
MX2016015688A (es) * 2014-06-10 2017-05-30 Dermtreat Aps Composiciones que comprenden fibras obtenidas electrohidrodinamicamente para la administracion de dosificaciones especificas de una sustancia activa a piel o mucosa.
CN105362269A (zh) * 2014-09-01 2016-03-02 天津药物研究院 一种含蔗糖的罗氟司特片及其制备方法
SG11201707988YA (en) * 2015-03-31 2017-10-30 Orthorebirth Co Ltd Method for manufacturing drug-containing biodegradable fiber material by electrospinning
EP3319779A4 (de) * 2015-07-07 2019-02-27 Singapore Health Services Pte Ltd Polymerprodukt und seine herstellung
CN105327357B (zh) * 2015-10-14 2019-01-11 北京科技大学 一种邻苯二酚修饰的透明质酸的载药系统及其制备方法
EP3334412B1 (de) * 2015-11-19 2021-10-20 Afyx Therapeutics A/S Pharmazeutische zusammensetzung mit elektrohydrodynamisch gewonnenen fasern sowie verbesserter verweilzeit an der auftragungsstelle
WO2017130141A1 (en) * 2016-01-27 2017-08-03 Instar Technologies A.S. Oromucosal nanofiber carriers for therapeutic treatment
CN105727358B (zh) * 2016-02-23 2019-01-22 广西易得佳医疗器械有限公司 载药生物高分子复合纳米纤维膜及其制备方法
CN105663025A (zh) * 2016-02-29 2016-06-15 浙江工业大学 一种含药微丝及其制备方法
BR112019014236A2 (pt) 2017-01-23 2020-03-17 Afyx Therapeutics A/S Método para a fabricação de um produto de duas camadas à base de fibras eletrofiadas
KR102595001B1 (ko) 2017-01-23 2023-10-26 에이에프와이엑스 테라퓨틱스 에스에이 높은 함량의 생체접착성 물질을 가지는 전기방사 섬유의 제조 방법
EP3573722B1 (de) 2017-01-27 2022-02-23 The Procter & Gamble Company Zusammensetzungen in form von löslichen festen strukturen mitagglomerierten brauseteilchen
JP7028877B2 (ja) 2017-01-27 2022-03-02 ザ プロクター アンド ギャンブル カンパニー 溶解性固形構造体形態の組成物
CN110650723A (zh) 2017-05-16 2020-01-03 宝洁公司 可溶性固体结构形式的调理毛发护理组合物
CN107447366A (zh) * 2017-08-03 2017-12-08 东华大学 一种pH敏感载药缓释纳米纤维膜及其制备方法和应用
JP7110355B2 (ja) 2018-01-26 2022-08-01 ザ プロクター アンド ギャンブル カンパニー 酵素を含む水溶性単位用量物品
JP7110356B2 (ja) 2018-01-26 2022-08-01 ザ プロクター アンド ギャンブル カンパニー 香料を含む水溶性単位用量物品
US11053466B2 (en) 2018-01-26 2021-07-06 The Procter & Gamble Company Water-soluble unit dose articles comprising perfume
JP7127135B2 (ja) 2018-01-26 2022-08-29 ザ プロクター アンド ギャンブル カンパニー 水溶性物品及び関連プロセス
WO2019168829A1 (en) 2018-02-27 2019-09-06 The Procter & Gamble Company A consumer product comprising a flat package containing unit dose articles
JP7121944B2 (ja) * 2018-05-07 2022-08-19 国立大学法人信州大学 ナノ繊維及びその製造方法
JP1639110S (de) 2018-07-16 2019-08-13
US10982176B2 (en) 2018-07-27 2021-04-20 The Procter & Gamble Company Process of laundering fabrics using a water-soluble unit dose article
US11666514B2 (en) 2018-09-21 2023-06-06 The Procter & Gamble Company Fibrous structures containing polymer matrix particles with perfume ingredients
CN113748195B (zh) 2019-01-28 2024-01-19 宝洁公司 可回收利用的、可再生的或可生物降解的包装
EP3712237A1 (de) 2019-03-19 2020-09-23 The Procter & Gamble Company Faserige wasserlösliche einmal-dosierartikel mit wasserlöslichen faserstrukturen
CA3134222C (en) 2019-06-28 2024-01-16 The Procter & Gamble Company Dissolvable solid fibrous articles containing anionic surfactants
MX2021015391A (es) 2019-07-03 2022-01-24 Procter & Gamble Estructuras fibrosas que contienen surfactantes cationicos y acidos solubles.
USD939359S1 (en) 2019-10-01 2021-12-28 The Procter And Gamble Plaza Packaging for a single dose personal care product
MX2022002875A (es) 2019-10-14 2022-03-25 Procter & Gamble Bolsita biodegradable y/o para compost domestico que contiene un articulo solido.
MX2022003979A (es) 2019-11-20 2022-04-26 Procter & Gamble Estructura solida soluble porosa.
EP4065068A1 (de) 2019-12-01 2022-10-05 The Procter & Gamble Company Haarkonditionierungsmittel mit einem konservierungssystem, das natriumbenzoat und glykole und/oder glycerylester enthält
USD941051S1 (en) 2020-03-20 2022-01-18 The Procter And Gamble Company Shower hanger
USD962050S1 (en) 2020-03-20 2022-08-30 The Procter And Gamble Company Primary package for a solid, single dose beauty care composition
USD965440S1 (en) 2020-06-29 2022-10-04 The Procter And Gamble Company Package
WO2022027067A1 (en) 2020-07-31 2022-02-03 The Procter & Gamble Company Water-soluble fibrous pouch containing prills for hair care
WO2022036354A1 (en) 2020-08-11 2022-02-17 The Procter & Gamble Company Low viscosity hair conditioner compositions containing brassicyl valinate esylate
EP4196234A1 (de) 2020-08-11 2023-06-21 The Procter & Gamble Company Haarkonditioniermittel zum sauberen spülen enthaltend brassicylvalinat esylat
EP4196233A1 (de) 2020-08-11 2023-06-21 The Procter & Gamble Company Feuchtigkeitsspendende haarpflegezusammensetzungen mit brassicylvalinat-esylat
JP2023553395A (ja) 2020-12-01 2023-12-21 ザ プロクター アンド ギャンブル カンパニー 可溶化抗ふけ活性物質を含有する水性ヘアコンディショナー組成物
CN113041230B (zh) * 2021-03-23 2022-06-24 浙江尖峰健康科技有限公司 一种软胶囊的囊皮及由其制备的软胶囊
KR102653460B1 (ko) * 2021-09-01 2024-03-29 한남대학교 산학협력단 콜라겐과 레시틴을 포함하는 분해도 조절이 가능한 스타치 나노섬유의 제조방법
WO2023145886A1 (ja) * 2022-01-31 2023-08-03 三菱ケミカル株式会社 ナノファイバー
CN114808184A (zh) * 2022-03-11 2022-07-29 深圳市法鑫忠信新材料有限公司 一种长效驱蚊的静电纺丝纤维及其制备方法和应用
CN115887422A (zh) * 2022-12-31 2023-04-04 兰州交通大学 一种高乌甲素膝骨关节镇痛缓释贴及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1527592A (en) * 1974-08-05 1978-10-04 Ici Ltd Wound dressing
US4855326A (en) * 1987-04-20 1989-08-08 Fuisz Pharmaceutical Ltd. Rapidly dissoluble medicinal dosage unit and method of manufacture
US5567439A (en) 1994-06-14 1996-10-22 Fuisz Technologies Ltd. Delivery of controlled-release systems(s)
US5736152A (en) * 1995-10-27 1998-04-07 Atrix Laboratories, Inc. Non-polymeric sustained release delivery system
US5869098A (en) * 1997-08-20 1999-02-09 Fuisz Technologies Ltd. Fast-dissolving comestible units formed under high-speed/high-pressure conditions
US5980941A (en) * 1997-08-20 1999-11-09 Fuisz Technologies Ltd. Self-binding shearform compositions
US6753454B1 (en) * 1999-10-08 2004-06-22 The University Of Akron Electrospun fibers and an apparatus therefor

Also Published As

Publication number Publication date
KR100806412B1 (ko) 2008-02-21
NZ519992A (en) 2004-04-30
EP1251829A1 (de) 2002-10-30
CA2396640A1 (en) 2001-08-02
HUP0301130A2 (hu) 2003-09-29
PL356924A1 (en) 2004-07-12
MY129356A (en) 2007-03-30
MXPA02007298A (es) 2002-12-09
KR20020082212A (ko) 2002-10-30
EP1251829A4 (de) 2009-05-06
TWI289061B (en) 2007-11-01
ZA200205989B (en) 2003-02-03
WO2001054667A1 (en) 2001-08-02
CN1396823A (zh) 2003-02-12
AU3113401A (en) 2001-08-07
NO20023338L (no) 2002-09-03
AR028204A1 (es) 2003-04-30
BR0107869A (pt) 2002-11-05
IL150642A0 (en) 2003-02-12
JP2003521493A (ja) 2003-07-15
AU772830B2 (en) 2004-05-06
CN1223340C (zh) 2005-10-19
NO20023338D0 (no) 2002-07-11

Similar Documents

Publication Publication Date Title
HUP0301130A3 (en) Electrospun pharmaceutical compositions
GB2358583B (en) Pharmaceutical compositions
EG24357A (en) New Pharmaceutical composition
HUP0300582A3 (en) Pharmaceutical compositions
AU6219601A (en) Pharmaceutical compositions
GB0009584D0 (en) Pharmaceutical compositions
AU8576801A (en) Pharmaceutical compositions
HUP0400553A3 (en) Pharmaceutical compositions
AU1390002A (en) Pharmaceutical compositions
GB0008485D0 (en) Pharmaceutical compositions
GB0009613D0 (en) Pharmaceutical compositions
GB0005382D0 (en) Pharmaceutical composition
GB0101094D0 (en) Pharmaceutical composition
GB0002691D0 (en) Pharmaceutical composition
GB0031288D0 (en) Pharmaceutical compositions
HU0700204D0 (en) Pharmaceutical compositions
GB0003929D0 (en) Pharmaceutical compositions
GB0001337D0 (en) Pharmaceutical compositions
GB0000062D0 (en) Pharmaceutical compositions
GB0018321D0 (en) Pharmaceutical compositions
GB0031282D0 (en) Pharmaceutical compositions
GB0008872D0 (en) Pharmaceutical compositions
HU0000060D0 (en) Novel pharmaceutical compositions
GB0006301D0 (en) Pharmaceutical composition
GB0016684D0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees